19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V92.7.2441.2441_2441_2449PMID 9746784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute promyelocytic leukemia

  2000cited by this paper
• p27Kip1 overexpression causes apoptotic death of mammalian cells

  1997cited by this paper
• Synergistic decrease of clonal proliferation, induction of differentiation, and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel 20-epi vitamin D3 analogs and 9-cis retinoic acid.

  1997cited by this paper
• 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.

  1997cited by this paper
• Transition to tetraploidy in 1,25-dihydroxyvitamin D3-resistant HL60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors.

  1996cited by this paper
• Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.

  1996cited by this paper
• Effects of 1,25-dihydroxy vitamin D3 on all-trans retinoic acid sensitive and resistant acute promyelocytic leukemia cells.

  1996cited by this paper
• Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.

  1996cited by this paper
• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis.

  1995cited by this paper
• Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

  1995cited by this paper
• Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia

  1995cited by this paper
• 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

  1995cited by this paper
• p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.

  1995cited by this paper
• 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a Noncalcemic Analogue of 1α,25-Dihydroxyvitamin D3, Inhibits Azoxymethane-induced Colonic Tumorigenesis

  1995cited by this paper
• Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.

  1995cited by this paper
• The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.

  1995cited by this paper
• Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.

  1995cited by this paper
• 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

  1994cited by this paper
• Induction of glioma cell death by 1,25 (OH)2 vitamin D3: Towards an endocrine therapy of brain tumors?

  1994cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.

  1994cited by this paper
• Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.

  1994cited by this paper
• 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.

  1994cited by this paper
• Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha.

  1994cited by this paper
• Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels.

  1993cited by this paper
• Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein levels

  1993cited by this paper
• Acute promyelocytic leukemia.

  1993cited by this paper
• NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

  1991cited by this paper
• Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

  1991cited by this paper
• Structure-Function Studies on Analogues of 1α,25-Dihydroxyvitamin D3: Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption

  1990cited by this paper
• 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice.

  1990cited by this paper
• Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.

  1990cited by this paper
• Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.

  1989cited by this paper
• Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.

  1987cited by this paper
• Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.

  1986cited by this paper
• Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea.

  1986cited by this paper
• 13-cis-retinoic acid in the treatment of oral leukoplakia.

  1986cited by this paper
• Potentiation by 1-α,25-0ihydroxyvitamin D3 of Cytotoxicity to HL-60 Cells Produced by Cytarabine and Hydroxyurea

  1986cited by this paper
• 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.

  1985cited by this paper
• Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide

  1979cited by this paper

• The Centennial Collection of VDR Ligands: Metabolites, Analogs, Hybrids and Non-Secosteroidal Ligands

  2022cites this paper
• Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation

  2021cites this paper
• Vitamin D Receptor Signaling and Cancer

  2017cites this paper
• Vitamin D receptor 2016: novel ligands and structural insights

  2016cites this paper
• Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells

  2012cites this paper
• Application of vitamin D and derivatives in hematological malignancies.

  2012cites this paper
• The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells

  2012cites this paper
• Vitamin D effects on differentiation and cell cycle

  2011cites this paper
• Novel Vitamin D Analogs for Prostate Cancer Therapy

  2011cites this paper
• The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines.

  2008cites this paper
• Vitamin D, vitamin D analogs (deltanoids) and prostate cancer

  2008cites this paper
• Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model

  2008cites this paper
• The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on αvβ3 integrin expression in cancer cell lines

  2008cites this paper
• Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors.

  2007cites this paper
• Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells.

  2007cites this paper
• Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.

  2007cites this paper
• The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.

  2007cites this paper
• Antitumor properties of diastereomeric and geometric analogs of vitamin D3

  2007cites this paper
• CHAPTER 27 – Differentiation Induction in Leukemia and Lymphoma

  2006cites this paper
• HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24.

  2006cites this paper
• 27-bishomo-Vitamin D 3 Analogs : A Unique Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Hematopoietic Cancer Cells 1

  2006cites this paper
• Hematopoietic Cancer Cells Potent Inhibitors of Proliferation of Prostate , Breast , and Analogs : A Unique Class of 319-nor-26 , 27-bishomo-Vitamin D Updated

  2006cites this paper
• Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.

  2005cites this paper
• Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug.

  2005cites this paper
• CHAPTER 92 – Differentiation and the Cell Cycle

  2005cites this paper
• Nouveaux analogues de calcitriol et leur utilisation

  2004cites this paper
• Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).

  2004cites this paper
• Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs.

  2004cites this paper
• Actual targets in cytodifferentiation cancer therapy.

  2004cites this paper
• Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.

  2004cites this paper
• Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid.

  2004cites this paper
• 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines.

  2003cites this paper
• 1α,25-Dihydroxyvitamin D3 (calcitriol) and its analogue, 19-nor-1α,25(OH)2D2, potentiate the effects of ionising radiation on human prostate cancer cells

  2003cites this paper
• Establishment of the acute myeloid leukemia cell line Kasumi‐6 from a patient with a dominant‐negative mutation in the DNA‐binding region of the C/EBPα gene

  2003cites this paper
• An update on the therapeutic potential of vitamin D analogues

  2003cites this paper
• Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells.

  2003cites this paper
• 19-Nor-1α,25-dihydroxyvitamin D2 (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines

  2003influential citation
• Cotylenin A--A Plant Growth Regulator as a Differentiation-inducing Agent Against Myeloid Leukemia

  2002cites this paper
• Chapter 31 – 1α,25(OH)2 Vitamin D3: Nuclear Receptor Structure and Ligand Specificities for Genomic and Rapid Biological Responses

  2002cites this paper
• Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.

  2001cites this paper
• Metabolism of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1α,25-dihydroxyvitamin D3 produced in HL-60 cells

  2001cites this paper
• Differentiation therapy of human cancer: basic science and clinical applications.

  2001cites this paper
• Baicalin is a major component of PC‐SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest

  2001cites this paper
• Cytodifferentiation: a novel approach to cancer treatment and prevention.

  2001cites this paper
• Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.

  2001cites this paper
• Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system.

  2001cites this paper
• Effects of vitamin D on the growth of normal and malignant B‐cell progenitors

  2001cites this paper
• 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.

  2001cites this paper
• Structure Function Studies: Identification of Vitamin D Analogs for the Ligand-Binding Domains of Important Proteins in the Vitamin D-Endocrine System

  2001cites this paper
• Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells.

  2001cites this paper
• Synthesis and biological activities of the two C(23) epimers of 1alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D(3): novel analogs of 1alpha,23(S),25-trihydroxy-24-oxo-vitamin D(3), a natural metabolite of 1alpha,25-dihydroxyvitamin D(3).

  2000cites this paper
• The anti-proliferative effects of 1α,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

  2000cites this paper
• Mechanisms for the selective actions of vitamin D analogues.

  2000cites this paper
• Synthesis and biological activities of the two C(23) epimers of 1α,23,25-trihydroxy-24-oxo-19-nor-vitamin D3: novel analogs of 1α,23(S),25-trihydroxy-24-oxo-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3

  2000cites this paper
• Differentiation therapy in acute myelogenous leukemia (non-APL)

  2000cites this paper
• Myelodysplasia

  2000cites this paper
• 6-trans-16-ene-Vitamin D 3 : A New Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Myeloid Leukemic Cells 1

  1999cites this paper
• Cells of Proliferation of Prostate , Breast , and Myeloid Leukemic : A New Class of Potent Inhibitors 3-16-ene-Vitamin D trans 5 , 6-Updated

  1999cites this paper
• Vitamin D Analogs, 20-Epi-22-Oxa-24a,26a,27a,-Trihomo-1α,25(OH)2-Vitamin D3, 1,24(OH)2-22-Ene-24-Cyclopropyl-Vitamin D3 and 1α,25(OH)2-Lumisterol3 Prime NB4 Leukemia Cells for Monocytic Differentiation via Nongenomic Signaling Pathways, Involving Calcium and Calpain1.

  1999cites this paper
• Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.

  1999cites this paper
• Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.

  1999cites this paper
• The cyclin‐dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+ progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells

  1999cites this paper
• Leukemia Cells for Monocytic Differentiation via Nongenomic Signaling Pathways , Involving Calcium and Calpain *

  1999cites this paper
• Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.

  1999cites this paper
• 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.

  1999cites this paper
• Molecular therapeutics of myelodysplasia and myelodysplasia-related leukaemias

  1999cites this paper
• Baicalin Is aMajorComponentof PC-SPESWhich Inhibits the ProliferationofHumanCancerCells

  year unknowncites this paper